methyl 2-((3-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)propyl)(methyl)amino)acetate

ID: ALA4066627

PubChem CID: 137632263

Max Phase: Preclinical

Molecular Formula: C19H20N2O4

Molecular Weight: 340.38

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  COC(=O)CN(C)CCCN1C(=O)c2cccc3cccc(c23)C1=O

Standard InChI:  InChI=1S/C19H20N2O4/c1-20(12-16(22)25-2)10-5-11-21-18(23)14-8-3-6-13-7-4-9-15(17(13)14)19(21)24/h3-4,6-9H,5,10-12H2,1-2H3

Standard InChI Key:  CEXZUDXEKIUCCN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
   22.7896   -5.9308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7896   -5.1095    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.0802   -4.6968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0802   -3.8755    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.3736   -5.1113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6696   -4.7032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9587   -5.1094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9587   -5.9320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6731   -6.3390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3736   -5.9295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0802   -6.3394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0802   -7.1504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3809   -7.5581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6731   -7.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5026   -4.7030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2133   -5.1137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9263   -4.7071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6337   -5.1207    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.3446   -4.7177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6337   -5.9420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3316   -6.3603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3316   -7.1816    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.6142   -7.5846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0467   -5.9532    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.5008   -6.3446    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  5  3  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
 10  9  1  0
 10  5  2  0
 11 10  1  0
 11  1  1  0
 12 11  2  0
 13 12  1  0
 14 13  2  0
  9 14  1  0
  2 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 21 24  2  0
  1 25  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA4066627

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 340.38

Molecular Weight (Monoisotopic): 340.1423

AlogP: 1.93

#Rotatable Bonds: 6

Polar Surface Area: 66.92

Molecular Species: NEUTRAL

HBA: 5

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 6.67

CX LogP: 1.61

CX LogD: 1.54

Aromatic Rings: 2

Heavy Atoms: 25

QED Weighted: 0.59

Np Likeness Score: -1.04

References

1. Klimenko K, Lyakhov S, Shibinskaya M, Karpenko A, Marcou G, Horvath D, Zenkova M, Goncharova E, Amirkhanov R, Krysko A, Andronati S, Levandovskiy I, Polishchuk P, Kuz'min V, Varnek A..  (2017)  Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents.,  27  (16): [PMID:28666733] [10.1016/j.bmcl.2017.06.035]

Source

Source(1):

• Scientific Literature